Categories: Gastrointestinal diseases, Liver diseases

Aliases & Classifications for Choledocholithiasis

MalaCards integrated aliases for Choledocholithiasis:

Name: Choledocholithiasis 12 54 43 15 17 71


External Ids:

Disease Ontology 12 DOID:11755
MeSH 43 D042883
UMLS 71 C0701818

Summaries for Choledocholithiasis

MalaCards based summary : Choledocholithiasis is related to cholecystitis and peritonitis. An important gene associated with Choledocholithiasis is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways/superpathways is Folate Metabolism. The drugs Midazolam and Meperidine have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and pancreas.

Wikipedia : 74 Common bile duct stone, also known as choledocholithiasis, is the presence of gallstones in the common... more...

Related Diseases for Choledocholithiasis

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 350)
# Related Disease Score Top Affiliating Genes
1 cholecystitis 31.7 GUSB GPT F2 ALB
2 peritonitis 31.0 F2 CRP ALB
3 cholelithiasis 31.0 UGT1A1 GPT GGT1 CRP ALB ABCB4
4 pancreatitis 30.8 SLC17A5 GGT1 CRP ALB
5 hepatic coma 30.6 GPT F2 ALB
6 liver cirrhosis 30.4 SLC17A5 GPT GGT1 F2 ALB
7 extrahepatic cholestasis 30.4 GPT GGT1 ALPP ABCB4
8 hepatic encephalopathy 30.4 SLC17A5 GPT F2 ALB
9 obstructive jaundice 30.3 SLC17A5 GPT GGT1 F2 CRP ALPP
10 cholestasis 30.3 SLC17A5 GPT GGT1 F2 ALPP ALB
11 acute kidney failure 30.3 GPT F2 ALB
12 gilbert syndrome 30.3 UGT1A1 GPT ALB
13 suppurative cholangitis 30.2 GPT GGTLC3 GGT2 GGT1 ABCB4
14 ascending cholangitis 30.2 GPT GGTLC3 F2 CRP ALB
15 portal hypertension 30.2 GPT F2 ALB
16 thrombophlebitis 30.1 F2 CRP ALB
17 drug-induced hepatitis 30.1 UGT1A1 GPT F2 ALB
18 cholangitis 30.1 SLC17A5 GPT GGT1 F2 CRP CEACAM5
19 sickle cell anemia 30.1 UGT1A1 F2 CRP ALB
20 bronchopneumonia 30.0 GUSB GPT CRP ALB
21 acute cystitis 29.9 GPT F2 CRP ALB
22 cholecystolithiasis 29.9 STK10 GPT ERVMER34-1 CRP CEACAM5
23 hyperthyroidism 29.9 GPT CRP ALPP ALB
24 autoimmune hepatitis 29.8 SLC17A5 GPT GGT1 F2 ALB
25 bile duct cancer 29.8 PCCA GPT CEACAM5 ALB
26 respiratory failure 29.8 GPT F2 CRP ALB
27 intestinal obstruction 29.7 GPT CRP CEACAM5 ALB
28 sclerosing cholangitis 29.7 GPT GGT1 F2 CEACAM5 ALB ABCB4
29 fatty liver disease 29.7 SLC17A5 GPT GGT1 CRP ALB
30 acute cholangitis 29.7 GPT GGTLC3 GGT2 GGT1 F2 CRP
31 neutropenia 29.6 UGT1A1 GUSB GPT CRP ALB
32 deficiency anemia 29.6 GGTLC3 GGT2 GGT1 CRP ALB
33 klatskin's tumor 29.5 PCCA GPT CEACAM5 ALB
34 alcohol use disorder 29.4 SLC17A5 GPT GGTLC3 GGT2 GGT1 ALB
35 primary biliary cirrhosis 29.3 SLC17A5 GPT GGT1 F2 ALPP ALB
36 bile duct cysts 29.0 PCCA GPT GGTLC3 GGT2 GGT1 CEACAM5
37 liver disease 29.0 UGT1A1 SLC17A5 GPT GGT1 F2 ALPP
38 bilirubin metabolic disorder 28.8 UGT1A1 SLC17A5 GPT GGTLC3 GGT2 GGT1
39 gallbladder disease 28.6 UGT1A1 GPT GGTLC3 GGT2 GGT1 CRP
40 cholangitis, primary sclerosing 28.5 PCCA GPT GGTLC3 GGT2 GGT1 F2
41 biliary tract disease 28.3 PCCA GPT GGTLC3 GGT2 GGT1 F2
42 bile duct disease 27.8 PCCA GPT GGTLC3 GGT2 GGT1 F2
43 gallbladder disease 1 10.8
44 acute pancreatitis 10.7
45 paraquat poisoning 10.6 SLC17A5 GPT
46 dipetalonemiasis 10.6 GPT ALB
47 hepatoportal sclerosis 10.5 GPT F2
48 non-a-e hepatitis 10.5 F2 ALB
49 antipyrine metabolism 10.5 F2 ALB
50 heterophyiasis 10.5 GPT ALB

Graphical network of the top 20 diseases related to Choledocholithiasis:

Diseases related to Choledocholithiasis

Symptoms & Phenotypes for Choledocholithiasis

Drugs & Therapeutics for Choledocholithiasis

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
Meperidine Approved Phase 4 57-42-1 4058
Etomidate Approved Phase 4 33125-97-2 36339 667484
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
Ceftriaxone Approved Phase 4 73384-59-5 5361919 5479530
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
Ofloxacin Approved Phase 4 82419-36-1 4583
8 Hypnotics and Sedatives Phase 4
9 Narcotics Phase 4
10 Anti-Anxiety Agents Phase 4
11 Anesthetics, General Phase 4
12 Psychotropic Drugs Phase 4
13 Analgesics, Opioid Phase 4
14 Analgesics Phase 4
15 GABA Modulators Phase 4
16 Anesthetics, Intravenous Phase 4
17 Neurotransmitter Agents Phase 4
18 Gastrointestinal Agents Phase 4
19 Anti-Bacterial Agents Phase 4
20 Antibiotics, Antitubercular Phase 4
21 Anti-Infective Agents Phase 4
22 Cytochrome P-450 Enzyme Inhibitors Phase 4
23 Pharmaceutical Solutions Phase 3
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713
Glucagon Approved 16941-32-5
Indomethacin Approved, Investigational 53-86-1 3715
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
Cefotaxime Approved 63527-52-6 5742673 456256
Cefoxitin Approved 35607-66-0 441199
Scopolamine Approved, Investigational 6533-68-2, 51-34-3 5184
Pancrelipase Approved, Investigational 53608-75-6
Vitamin A Approved, Nutraceutical, Vet_approved 22737-96-8, 68-26-8, 11103-57-4 9904001 445354
33 Tissue Plasminogen Activator Early Phase 1
34 Plasminogen Early Phase 1
35 Disinfectants
36 Chlorhexidine gluconate
37 Anti-Infective Agents, Local
38 Glucagon-Like Peptide 1
39 Anesthetics
Bilirubin 69853-43-6, 635-65-4 21252250 5280352
41 Cephalosporins
42 Butylscopolammonium Bromide
43 Retinol palmitate
44 retinol
45 Liver Extracts
46 pancreatin
47 Hemostatics

Interventional clinical trials:

(show top 50) (show all 72)
# Name Status NCT ID Phase Drugs
1 Endoscopic Treatment of Difficult Bile Duct Stones: Use of Direct Visualization System ("Spyglass Direct Visualization System") Associated With Electrohydraulic Lithotripsy (EHL) X Hydrostatic Balloon Dilation of the Major Duodenal Papilla Unknown status NCT02703077 Phase 4
2 Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP) Completed NCT02027311 Phase 4 Etomidate;Midazolam;Meperidine
3 Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie Completed NCT00161083 Phase 4 ursodeoxycholic acid
4 Randomized Trial of Short Antibiotic Course to Decrease Post ERCP Cholangitis Recruiting NCT03087656 Phase 4 Ceftriaxone;Levofloxacin
5 Effect of Saline Irrigation to Decrease Rate of Residual Common Bile Duct Stones Unknown status NCT01425177 Phase 3
6 Endoscopic Sphincterotomy Plus Large-Balloon Dilatation (ESLBD) Versus Conventional Endoscopic Treatment for Removal of Large Common Bile Duct Stones : A Prospective Comparative Multi Center Randomized Study Completed NCT02592811 Phase 3
7 Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction Terminated NCT01424657 Phase 3
8 The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis Showing the High Level of Aminotransferase and the Establishment of New Nomenclature ; Gallstone Hepatitis Unknown status NCT02647593
9 Laparoendoscopic Rendez Vous (Intraoperative ERCP) vs Two Stage Approach (Preoperative ERCP Followed by Laparoscopic Cholecystectomy) for the Management of Cholelithiasis/Choledocholithiasis Unknown status NCT00416234
10 Comparison of Endoscopic Papillary Balloon Dilatation and Sphincterotomy for CBD Stones With Difficult Sphincterotomy or Distal CBD Tapering Unknown status NCT00329888
11 A Prospective Randomized Multicenter Study Comparing Different Dilation Durations During Endoscopic Papillary Balloon Dilatation for Bile Duct Stones. Unknown status NCT00451581
12 Initial Cholecystectomy With Intraoperative Cholangiography for Patients at Intermediate Risk of Common Bile Duct Stone Migration : Prospective Validation and Analysis Unknown status NCT02461147
13 Clinical Study of Abdominal Drainage in Laparoscopic Common Bile Duct Exploration With Primary Closure Unknown status NCT03120754
14 Prospective Study of Bacteremia and Infection Rates Following Cholangioscopy With the Spyglass Cholangioscope Unknown status NCT01414400
15 Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope Unknown status NCT02276157
16 Gastrointestinal Microbiomes in Patients of Recurrent Common Bile Duct Stones After Endoscopic Sphincterotomy(EST) Unknown status NCT03102281
17 Prospective Randomized Clinical Study for Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary Pancreatitis Unknown status NCT01687959 Early Phase 1
18 Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders Unknown status NCT01438385
19 Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP Completed NCT03074201
20 Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted Stone Completed NCT00173368
21 A Randomized Controlled Trial Comparing Post-operative Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy Completed NCT01824186
22 Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD Completed NCT01673269
23 Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis on Patients With choledocholithiasis--a Prospective Randomized Trial Completed NCT02594891
24 Preoperative Versus Intraoperative Endoscopic Sphincterotomy for Management of Choledocholithiasis and Cholecystolithiasis Completed NCT01046552
25 Loop-tipped Guidewire in Selective Biliary Cannulation: a Prospective, Randomized, Controlled Trial Completed NCT02028845
26 The Laryngeal Mask Airway Supreme (TM) is an Effective Alternative to Laryngoscope-guided Tracheal Intubation for Patients Undergoing Elective Laparoscopic Cholecystectomy-- A Prospective Randomized Controlled Trial Completed NCT02037958
27 Routine Bile Collection for Microbiological Analysis During Cholangiography and Its Impact on Management of Cholangitis: Results of a Prospective Study Completed NCT01003782
28 Inmediate Feeding Tolerance in Patients With Mild and Acute Biliary Pancreatitis vs Early Feeding Completed NCT03354065
29 "Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis: A Prospective Study in a Peripheral-Level Hospital" Completed NCT04213092
30 Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones Completed NCT01683240
31 Success of Routine Intraoperative Cholangiography Completed NCT04052633
32 Laparoscopy-Assisted Transgastric Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis After Roux-en-Y Gastric Bypass Completed NCT03925766
33 Role of Complete Blood Picture in Predicting the Etiology of Extrahepatic Cholestasis Completed NCT03237247
34 A Prospective, Randomized Study Comparing Efficacy and Safety Between Left Lateral Position and Prone Position for Endoscopic Retrograde Cholangiopancreatography Completed NCT02594475
35 Prospective Evaluation of Residual Bile Duct Stone Detection by Peroral Cholangioscopy That Is Missed With Conventional ERCP and Cholangiogram Completed NCT03482375
36 A Prospective Randomized Trial Comparing EUS Guided ERCP Without Fluoroscopy With Standard ERCP in Common Bile Duct Stone Removal Completed NCT02870686
37 Early Endoscopic Ultrasound (EUS) in Acute Biliary Pancreatitis: a Prospective Pilot Study Completed NCT02430285
38 ERCP in Super-aged Patients Considering Difficult Cannulation: Challenges and Adverse Events Completed NCT03771547
39 Prospective Randomized Trial of Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration (LC + LCBDE) Versus Endoscopic Retrograde Cholangiopancreatography Sphincterotomy Plus Laparoscopic Cholecystectomy (ERCP/S + LC) for Common Bile Duct Stone Disease Completed NCT00807729
40 Common Bile Duct Stone Management: What Have we Learned? Completed NCT02155244
41 Randomized Trial of Combination of Cholangioscopic Guided Laser Lithotripsy and Conventional Mechanical Versus Conventional Mechanical Methods for the Endoscopic Removal of Large Bile Duct Stones Completed NCT01759979
42 Cytological Evaluation of Biliary Epithelium After Previous Endoscopic Sphincterotomy for Benign Disease Completed NCT01135732
43 Ethical Committee at Researches of Ege University Completed NCT04410640
44 EPBD+Small EST VS. Large EST in Patients With Choledocholithiasis Complicated With Duodenal Papillary Diverticula Recruiting NCT04254887
45 Role of EUS in High Risk of Choledocholithiasis Recruiting NCT03250286
46 Division of Hepato-gastroenterology; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,Taiwan Recruiting NCT03754491
47 Endosonography Versus Magnetic Resonance Cholangiopancreatography for Choledocholithiasis for Intermediate Risk of Choledocholithiasis (as Per European Society of Gastrointestinal Endoscopy Guidelines )- Randomized Controlled Trial Recruiting NCT04173624
48 Comparison of Two Management Strategies, "Endoscopy First" and "Laparoscopic Cholecystectomy First", for Patients With Gallbladder Stones and Intermediate Risk for Choledocholithiasis Recruiting NCT03658863
49 If Chronic Gallbladder Diseases Increase the Occurence of Post Endoscopic Retrograde Choledochopancreatography Choledocholithiasis(a Prospective Multi-center Cohort Study) Recruiting NCT04242394
50 Does the Gallbladder Status Influence the Occurence of Post-Endoscopic Retrograde Choledochopancreatography(ERCP) -Choledocholithiasis Recruiting NCT04234126

Search NIH Clinical Center for Choledocholithiasis

Cochrane evidence based reviews: choledocholithiasis

Genetic Tests for Choledocholithiasis

Anatomical Context for Choledocholithiasis

MalaCards organs/tissues related to Choledocholithiasis:

Liver, Testes, Pancreas, Colon, Kidney, Heart, Bone

Publications for Choledocholithiasis

Articles related to Choledocholithiasis:

(show top 50) (show all 3831)
# Title Authors PMID Year
Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis. 54 61
16078299 2005
Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. 61 54
15667485 2005
[Usefulness of endoscopic cholangiography and sphincterotomy in patients with biliary lithiasis]. 61 54
15765973 2004
[Predictors of choledocholithiasis in patients sustaining gallstones]. 61 54
15286869 2004
Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis. 61 54
9383634 1997
Increased intercellular adhesion molecule-1 serum concentration in cholestasis. 61 54
9007716 1996
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. 61 54
8677945 1996
Jaundice. 61 54
1543099 1992
EUS-Directed Transgastric Endoscopic Retrograde Cholangiopancreatography (EDGE): The First Learning Curve. 61
32149820 2020
Risk factors for complications after cholecystectomy for common bile duct stones: An EAST multicenter study. 61
32466829 2020
Concomitant laparoscopic cholecystectomy and antegrade wire, rendezvous cannulation of the biliary tree may reduce post-ERCP pancreatitis events. 61
31489502 2020
Usefulness of endoscopic nasobiliary drainage-guided ERCP in patients with surgically altered anatomy (with video). 61
32490167 2020
A complex case of low-phospholipid-associated cholelithiasis syndrome. 61
32543870 2020
Choledocholithiasis in autosomal dominant polycystic kidney disease. 61
32553703 2020
Predicting common bile duct stones by non-invasive parameters. 61
31810810 2020
A new variant of double common bile duct associated with choledochal cyst. 61
32577210 2020
Cost effectiveness of intraoperative laparoscopic ultrasound for suspected choledocholithiasis; outcomes from a specialist benign upper gastrointestinal unit. 61
32538107 2020
Laparoscopic transcystic common bile duct exploration (LTCBDE): a safer method to treat common bile duct stones than laparoscopic choledochotomy. 61
32496116 2020
Unsual Aspect of a Choledocholithiasis. 61
32504640 2020
Differences between residual and primary choledocholithiasis in cholecystectomy patients. 61
32496117 2020
Unsuspected choledocholithiasis found by routine intra-operative cholangiography during laparoscopic cholecystectomy. 61
32536007 2020
Response to: Approach to evaluation of choledocholithiasis in patient with or without acute cholangitis. 61
32125414 2020
Acute cholecystitis and residual choledocholithiasis in a situs inversus patient, successful laparoscopic approach and ERCP a case report from Ecuador. 61
32426127 2020
Laparoendoscopic rendezvous versus ERCP followed by laparoscopic cholecystectomy for the management of cholecysto-choledocholithiasis: a retrospectively cohort study. 61
31428853 2020
Post-endoscopic retrograde cholangiopancreatography pancreatitis in single-stage endoscopic common bile duct stone removal. 61
32514443 2020
Endoscopic treatment of biliary complications after liver transplantation. 61
32543875 2020
Self-reported and actual adherence to the Tokyo guidelines in the European snapshot audit of complicated calculous biliary disease. 61
32418332 2020
Laparoscopic management of type II Mirizzi syndrome. 61
32140861 2020
Biloma: A Rare Manifestation of Spontaneous Bile Leak. 61
32542169 2020
Perioperative outcomes of the patients treated using laparoscopic cholecystectomy after emergent endoscopic retrograde cholangiopancreatography for bile duct stones: Does timing matter? 61
32436986 2020
Upper Gastrointestinal Bleeding With Hemobilia Caused by Gallstones. 61
32354592 2020
What constitutes urgent endoscopy? A social media snapshot of gastroenterologists' views during the COVID-19 pandemic. 61
32355889 2020
The Role of Laparoscopic Ultrasonography in the Evaluation of Suspected Choledocholithiasis. A Single-Center Experience. 61
32443814 2020
Laparoscopic trans-gastric endoscopic retrograde cholangiopancreatography during emergent cholecystectomy after Roux-en-Y gastric bypass: novel techniques for choledocholithiasis. 61
31478330 2020
Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: A single-center retrospective cohort study. 61
32376307 2020
The effect of a simple simulator on the application of laparoscopic common bile duct exploration in a low volume center. 61
32456389 2020
One-stage laparoscopic procedure versus two-stage procedure in the management of common bile duct stones in patients aged 75 and more. 61
31473141 2020
Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters. 61
31991114 2020
Clinical spotlight review for the management of choledocholithiasis. 61
32095952 2020
Comparison of the safety and efficacy of single-stage endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy versus two-stage ERCP followed by laparoscopic cholecystectomy six-to-eight weeks later: A randomized controlled trial. 61
32105889 2020
What Can be Done for Large and Multiple Choledochal Stones? 61
32513369 2020
A pictorial review of gall stones and its associated complications. 61
31931279 2020
Alterations of the bile microbiome in primary sclerosing cholangitis. 61
31243055 2020
Transductal versus transcystic laparoscopic common bile duct exploration: an institutional review of over four hundred cases. 61
32246237 2020
Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention. 61
32340857 2020
Laparoscopic common bile duct exploration for elderly patients with choledocholithiasis: a systematic review and meta-analysis. 61
32016517 2020
Implementation of a simplified self-releasing biliary stent in choledocholithiasis: Experience in 150 cases. 61
31074126 2020
Novel Percutaneous Image Guided Treatment of Choledocholithiasis in a 30-day-old Infant. 61
32304553 2020
Long-term outcomes and risk factors of recurrent biliary obstruction after permanent endoscopic biliary stenting for choledocholithiasis in high-risk patients. 61
32223015 2020
Same anesthesia ERCP and laparoscopic cholecystectomy in the Pediatric ERCP Database Initiative (PEDI) Experience. 61
32304542 2020

Variations for Choledocholithiasis

Expression for Choledocholithiasis

Search GEO for disease gene expression data for Choledocholithiasis.

Pathways for Choledocholithiasis

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
Show member pathways
11.35 GGT2 GGT1 F2 CRP ALB

GO Terms for Choledocholithiasis

Cellular components related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.32 STK10 GUSB GPT GGTLC3 GGT2 GGT1

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 acute-phase response GO:0006953 9.43 UGT1A1 F2 CRP
2 regulation of immune system process GO:0002682 9.32 GGT2 GGT1
3 peptide modification GO:0031179 9.16 GGT2 GGT1
4 glutathione catabolic process GO:0006751 9.13 GGTLC3 GGT2 GGT1
5 leukotriene D4 biosynthetic process GO:1901750 8.8 GGTLC3 GGT2 GGT1

Molecular functions related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidyltransferase activity GO:0000048 8.96 GGT2 GGT1
2 glutathione hydrolase activity GO:0036374 8.8 GGTLC3 GGT2 GGT1

Sources for Choledocholithiasis

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....